Clinical Trials List
2020-10-26 - 2028-06-30
Phase III
Not yet recruiting3
Recruiting5
ICD-9185
Malignant neoplasm of prostate
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Ching-Chia Li 未分科
- 黃俊農 未分科
- 李政學 未分科
- Tsung-Yi Huang 未分科
- Tsu-Ming Chien 未分科
- Sheng-Chen Wen 無
- Yung-Chin Lee 未分科
- Hsiang Ying Lee 未分科
- Hung-Lung Ke 無
- 阮雍順 未分科
- Shu-Pin Huang 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chao-Hsiang Chang Division of Urology
- 陳冠亨 Division of Urology
- 謝德鈞 Division of Nuclear Medicine
- Yu-De Wang Division of Urology
- Po-Fan Hsieh Division of Urology
- Che-Hung Lin Division of Hematology & Oncology
- Po-Jen Hsiao Division of Urology
- Chi-Ping Huang Division of Urology
- Su-Peng Yeh Division of General Internal Medicine
- Ching-Chan Lin Division of Hematology & Oncology
- Chi-Rei Yang Division of Urology
- Yi-Huei Chang Division of Urology
- Wei-Ching Lin Division of Radiology
- 蔡禮賢 Division of Urology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 蔡世傳 Division of Nuclear Medicine
- 洪晟鈞 Division of Urology
- Chuan-Shu Chen Division of Urology
- 熊小澐 Division of Radiology
- 林嘉彥 Division of Urology
- 盧嘉文 Division of Urology
- 裘坤元 Division of Urology
- Cheng-Kuang Yang Division of Urology
- 林雁婷 Division of Radiology
- 王樹吉 Division of Urology
- Jian-Ri Li Division of General Internal Medicine
- 梅承恩 Division of Emergency Medicine
- Cheng-Che Chen Division of Urology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Yeong-Shiau Pu Division of Urology
- 劉詩彬 Division of Urology
- 曾啟新 Division of Urology
- Yu-Chieh Tsai Division of Hematology & Oncology
- - - 無
- 馮國剛 Division of Urology
- SHUO-MENG WANG Division of Urology
- 王中傑 Division of Others
- JHE-CYUAN GUO 無
- YI-KAI CHANG 無
- 洪士鈞 Division of Urology
- CHING-CHU LU Division of Nuclear Medicine
- YU-CHUAN LU
- FU-JEN HSUEH Division of Hematology & Oncology
- Hong-Chiang Chang Division of Urology
- PO-MING CHOW Division of Urology
- Ying-Chun Shen Division of Hematology & Oncology
- CHUNG-HSIN CHEN 無
- JIAN-HUA HONG Division of Urology
- 闕士傑 Division of Urology
- 曾啟新 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yuan-Cheng Chu Division of Hematology & Oncology
- 黃成之 Division of Radiology
- 曾敬仁 Division of Nuclear Medicine
- 范綱行 Division of Radiation Therapy
- 黃成之 Division of Emergency Medicine
- Po-Jung Su Division of Hematology & Oncology
- Jing-Ren Tseng Division of Nuclear Medicine
- PO-HUNG LIN Division of Hematology & Oncology
- Yung-Chang Lin Division of Hematology & Oncology
- I-hung Shao Division of Hematology & Oncology
- Rita cheng Division of Urology
- See-Tong Pang Division of Hematology & Oncology
- Hong-Cheng Gan Division of Hematology & Oncology
- 吳俊德 Division of Urology
- Feng-Yuan Liu Division of Nuclear Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃詩喻 Division of Hematology & Oncology
- 鄭元佐 Division of Urology
- 王弘仁 Division of Urology
- 張雁翔 Division of Nuclear Medicine
- 陳彥豪 Division of Hematology & Oncology
- 賴香蘭 Division of Hematology & Oncology
- 陳彥達 Division of Urology
- 常景棣 Division of Radiology
- 吳佳哲 Division of Hematology & Oncology
- 康智雄 Division of Urology
- 羅浩倫 Division of Urology
- 劉建廷 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tzu-chun Wei Division of Urology
- 陳威任 Division of Urology
- I-Shen Huang 未分科
- Yen-Hwa Chang Division of Urology
- William Huang Division of Urology
- Chien-Hsin Ting Division of Nuclear Medicine
- Tzu-Hao Huang Division of Urology
- 潘競成 Division of Others
- 沈書慧 Division of Radiology
- Tzu-Ping Lin Division of Urology
- Hsiao-Jen Chung Division of Urology
- Chih-Chieh Lin Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
692 participants